Post-prandial glycaemic reduction by an alpha-glucosidase inhibitor in type 2 diabetic patients with therapeutically attained basal normoglycaemia.
Post-prandial glycaemic reduction by an alpha-glucosidase inhibitor in diabetic patients with therapeutically achieved basal normoglycaemia.